B.i.G has been actively seeking, growth oriented healthcare services and products. These investments take the form of build-ups as well as providing capital to rapidly growing entrepreneurial enterprises, recapitalization and acquisition.
B.i.G areas of focus include, early stage drug discovery services, Preclinical services, Clinical services as well as enabling technologies in all these areas.
For each individual investment, B.i.G can commit up to $35m of equity, convertible notes/equity, and line of credit. Preferred characteristics of these include:
BIG companies get the benefit of close working relationship with its partners. This enables the access to wide range of expertise as well as networking to further their business objectives.